PRKCE and pancreatic neoplasm: To investigate the potential role of PKCε as a downstream mediator of the survival-promoting effects of 5-Lox, pancreatic cancer cells were treated with MK591 or 5-Lox shRNA which showed a decrease in the expression of PKCε (Figures 5B, C).